CE marking will continue to be accepted in Great Britain until 30 June 2028 for medical devices. It will be accepted until 30 June 2030 for IVDs. Then, UKCA marking will become mandatory. Manufacturers should prepare now by appointing a UK Responsible Person....
UKCA post-market surveillance (PMS) is a legal obligation under the UK Medical Devices Regulations, overseen by the MHRA. It requires medical device manufacturers to maintain a structured system for monitoring device safety and performance after market approval. The...
UK Conformity Assessed (UKCA) is the United Kingdom’s product marking introduced on 1 January 2021 after Brexit. UKCA shows that a product meets the health, safety, and environmental protection standards required by UK law. It applies to goods sold in Great Britain...
Risk assessment in pharma industry is a systematic evaluation of hazards, their probability, and severity. It is followed by decisions on control measures. Basically, it is a structured process of identifying, analyzing, and controlling potential hazards that could...
European Union Medical Device Regulation (EU MDR) has replaced the previous Medical Device Directive (MDD). It aims to address gaps in oversight and improve patient safety. EU MDR introduces stricter requirements for clinical evaluation, post-market surveillance,...